Tornier Announces Conference Call of Second Quarter Results

AMSTERDAM--(BUSINESS WIRE)-- Tornier N.V. (NASDAQ:TRNX), announced today its second quarter 2011 conference call will be held on Tuesday, August 9, 2011 at 5:30 p.m. eastern time following a news release earlier that afternoon which will detail the Company’s financial results.

Conference call dial-in information is as follows:

  • U.S. callers: 877 - 673 - 5355
  • International callers: +1 - 760 - 666 - 3805

A digital recording will be available 2 hours after the completion of the conference call through its website, www.tornier.com.

About Tornier

Tornier is a global medical device company focused on serving extremities specialists who treat orthopedic conditions of the shoulder, elbow, wrist, hand, ankle and foot. The Company’s broad offering of over 80 product lines includes joint replacement, trauma, sports medicine, and biologic products to treat the extremities, as well as joint replacement products for the hip and knee in certain international markets. Since its founding approximately 70 years ago, Tornier’s “Specialists Serving Specialists” philosophy has fostered a tradition of innovation, intense focus on surgeon education, and commitment to advancement of orthopedic technology stemming from its close collaboration with orthopedic surgeons and thought leaders throughout the world. For more information regarding Tornier, visit www.tornier.com.



CONTACT:

Tornier
Carmen Diersen, +31 (0)20 675 40 02
Chief Financial Officer
[email protected]

KEYWORDS:   United States  Europe  North America  Netherlands  Minnesota

INDUSTRY KEYWORDS:   Surgery  Health  Hospitals  Medical Devices

MEDIA:

Logo
 Logo

Suggested Articles

The profit margins and management of Community Health Group raise questions about oversight of managed care insurers.

Financial experts are warning practices about the pitfalls of promoting medical credit cards to their patients.

A proposed rule issued by HHS on Tuesday would expand short-term coverage, a move Seema Verma said will have "virtually no impact" on ACA premiums.